浙江医药：累计回购约1372万股

Core Viewpoint - Zhejiang Medicine announced the completion of a share buyback, acquiring approximately 13.72 million shares, which represents 1.43% of the company's total equity, at an average price of 14.57 CNY per share, totaling around 200 million CNY in funds used [1] Group 1: Share Buyback Details - The company completed the buyback on August 11, 2025, through a centralized bidding method on the Shanghai Stock Exchange [1] - The highest buyback price was 16.09 CNY per share, while the lowest was 13.31 CNY per share [1] - The total number of shares repurchased was approximately 13.72 million [1] Group 2: Revenue Composition - For the year 2024, the revenue composition of Zhejiang Medicine is as follows: human nutritional products accounted for 50.1%, pharmaceuticals for 48.85%, and other businesses for 1.05% [1] - The contribution from other businesses includes 0.64% from other categories and 0.41% from additional services [1] Group 3: Market Capitalization - As of the report, Zhejiang Medicine's market capitalization stands at 15 billion CNY [1]